Related Experiment Video

Updated: Jul 7, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

DNA analysis in inherited cardiomyopathies: current status and clinical relevance

Karin Y van Spaendonck-Zwarts1, Maarten P van den Berg, J Peter van Tintelen

  • 1Department of Clinical Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. k.y.spaendonck@medgen.umcg.nl

Pacing and Clinical Electrophysiology : PACE
|March 25, 2008
PubMed

Insights

Genetic testing for cardiomyopathies aids diagnosis and identifies at-risk relatives. Understanding genotype-phenotype links helps target DNA analysis for clinical decisions in inherited heart muscle diseases.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Familial cardiomyopathies, including hypertrophic, dilated, and arrhythmogenic right ventricular types, are often inherited.
  • These conditions typically follow an autosomal dominant inheritance pattern.
  • Underlying genetic mutations affect proteins crucial for sarcomere, cytoskeleton, nuclear envelope, and desmosome structure and function.

Purpose of the Study:

  • To explore the diagnostic and clinical utility of DNA analysis in cardiomyopathies.
  • To investigate the role of genotype-phenotype correlations in guiding genetic testing and clinical management.

Main Methods:

  • Review of genetic databases and clinical case studies.
  • Analysis of DNA sequencing data from patients with various cardiomyopathies.
  • Correlation of specific genetic mutations with clinical phenotypes, including morphology and electrocardiogram parameters.

Main Results:

  • DNA analysis can confirm diagnoses in ambiguous cases of cardiomyopathy.
  • Cascade screening effectively identifies at-risk family members.
  • Specific genotype-phenotype associations, such as septal morphology linked to certain genes, were observed.

Conclusions:

  • Genetic testing is a valuable tool for diagnosing and managing inherited cardiomyopathies.
  • Understanding genotype-phenotype relationships aids in targeted DNA testing strategies.
  • DNA analysis results inform clinical decision-making for patients and families affected by cardiomyopathies.

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover08:03

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover

Published on: May 23, 2016

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...